Global Cefuroxime API Prices Stabilize: China’s Export and U.S. Demand Drive Market Confidence

Key Highlights: 

• The cefuroxime market remains buoyed by strong demand from antibiotic manufacturers, particularly in the U.S., as seasonal respiratory infections drive stockpiling.
• As the primary producer, China’s cefuroxime exports set the global price benchmark, with U.S. import prices closely mirroring FOB Shanghai trends.
• The approach of the flu season in Q* **** is accelerating procurement, supporting price stability and incremental gains.
• Stable shipping costs on major Asia-U.S. routes ensure uninterrupted supply chains, mitigating potential price volatility.

Cefuroxime FOB Shanghai (China) prices slightly increased from USD ***,***/MT in August to USD ***,***/MT in September, while CFR Los Angeles (USA) also shifted in sync from USD ***,***/MT to USD ***,***/MT. Cefuroxime is seeing a *.*** weekly price increase in China and a *.*** rise in the U.S., which reflects consistent demand. Pharma, especially the U.S., continues to be the pillar, with antibiotic manufacturing picking up speed prior to the flu season in...